Drug Utilization and Drug-Drug Interaction Studies in the Field: Examples of South-North Collaboration Projects

被引：0
|
作者：
Kuemmerle, A. [1 ,2 ]
Akakpo, S. [3 ]
Liwono, J. [3 ,4 ]
Duparc, S. [3 ]
Burri, C. [1 ,2 ]
Stergachis, A. [5 ,6 ]
机构：
[1] Swiss Trop & Publ Hlth Inst, Basel, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Med Malaria Venture, Geneva, Switzerland
[4] Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO
[5] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
[6] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA
来源：
DRUG SAFETY | 2018年 / 41卷 / 11期
关键词：
MEDICINAL-PLANTS;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
O-032
引用
收藏
页码：1120 / 1121
页数：2
相关论文
共 50 条
  • [31] Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons Learned
    Younis, Islam R.
    Lakota, Elizabeth A.
    Volpe, Donna A.
    Patel, Vikram
    Xu, Yun
    Sahajwalla, Chandra G.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (08): : 1035 - 1043
  • [32] Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects
    J M A Sitsen
    F A Maris
    C J Timmer
    European Journal of Drug Metabolism and Pharmacokinetics, 2001, 26 : 109 - 121
  • [33] Drug-drug interaction studies with Harpagophytum procumbens (Devil's claw)
    Appel, K
    McGregor, GP
    DRUG SAFETY, 2006, 29 (04) : 358 - 358
  • [34] Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects
    Sitsen, JMA
    Maris, FA
    Timmer, CJ
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2001, 26 (1-2) : 109 - 121
  • [35] The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective
    Bjornsson, TD
    Callaghan, JT
    Einolf, HJ
    Fischer, V
    Gan, L
    Grimm, S
    Kao, J
    King, SP
    Miwa, G
    Ni, L
    Kumar, G
    McLeod, J
    Obach, SR
    Roberts, S
    Roe, A
    Shah, A
    Snikeris, F
    Sullivan, JT
    Tweedie, D
    Vega, JM
    Walsh, J
    Wrighton, SA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (05): : 443 - 469
  • [36] How Far Should We Go? Perspective of Drug-Drug Interaction Studies in Drug Development
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (03) : 227 - 228
  • [37] DRUG-DRUG INTERACTION DATABASES: SENSITIVITY AND SPECIFICITY TO DETECT MANIFEST DRUG-DRUG INTERACTIONS, RELIABILITY RATINGS AND MANAGEMENT STRATEGIES OF POTENTIAL DRUG-DRUG INTERACTIONS
    Ocovska, Z.
    Marikova, M.
    Kukralova, K.
    Vlcek, J.
    VALUE IN HEALTH, 2022, 25 (01) : S140 - S141
  • [38] Drug-drug interaction from the standpoint of pharmacokineties
    Ohdo, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 28P - 28P
  • [39] Opioid metabolism and drug-drug interaction in cancer
    Aapro, Matti
    Fogli, Stefano
    Morlion, Bart
    Danesi, Romano
    ONCOLOGIST, 2024, 29 (11): : 931 - 942
  • [40] A Drug-drug Interaction Between Cyclosporine and Nystatin
    Liu, Wei
    Guan, Xin
    Yu, Zhiheng
    Chen, Ken
    Benet, Leslie
    Zhai, Suodi
    CLINICAL THERAPEUTICS, 2018, 40 (04) : 660 - 662
12345